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Purpose: The CERKL gene encodes for ceramide kinase-like, a novel protein of unknown function. CERKL mutations
are associated with a severe retinal phenotype. The purpose of this work was to investigate alternative splicing, and the
temporal and spatial expression pattern of CERKL in the mouse retina.
Methods: Reverse Transcription-Polymerase Chain Reaction (RT–PCR) analysis of mouse retina RNA was used to study
the expression of Cerkl at various developmental time points, and to identify its various splice-isoforms. A specific anti-
CERKL antibody was developed and used for immunostaining to study the localization of the endogenous CERKL protein
in retina-derived cell lines and in the mouse retina.
Results: Cerkl is expressed in the mouse eye as early as embryonic day 14. A total of seven different Cerkl splice-isoforms
were identified in the mouse retina. The subcellular localization of CERKL in retina-derived cell lines is variable: CERKL
is diffusely distributed in the cytoplasm, and in many cells, it is highly concentrated in the perinuclear region. In most,
but not all cells, CERKL is also highly concentrated in the nucleus. In the mouse retina, CERKL is located in the ganglion
cell layer, in amacrine cells of the inner nuclear layer, and in photoreceptors. CERKL is highly expressed in cone
photoreceptors; however, its expression level in rod photoreceptors is very low. In cultured cells, CERKL is detected in
the nucleus, but in retinal cells in situ, it is mostly located in the cytoplasm.
Conclusions: The expression of Cerkl in both mature and embryonic mouse retina and the severe retinal phenotype
associated with human CERKL mutations indicate that this gene plays a crucial role in retinal activity, and that it may be
important for retinal development as well. The high expression level of CERKL in cones correlates with the CERKL-
associated phenotype in humans. Whether nucleocytoplasmic transport of CERKL actually occurs in vivo under certain
conditions and its functional significance remain to be discovered.
Hereditary retinal degeneration (HRD) is a clinically and
genetically heterogeneous group of diseases that cause visual
loss due to progressive loss of rod and/or cone photoreceptor
cells in the retina [1]. In cone-rod degeneration (CRD), cone
involvement initially exceeds that of rods, and thus, reduced
visual acuity, photophobia, and defective color vision are
prominent  early  symptoms  [2].  Rod  photoreceptor
degenerations involve a secondary loss of cones and are called
retinitis pigmentosa (RP). RP classically manifests with night
blindness and progressive peripheral visual field loss [3].
The  RP26  locus  was  originally  mapped  to  human
chromosome 2q31-q33 in a large Spanish family [4]. The
underlying gene was identified in 2004 and named ceramide
kinase-like (CERKL) [5]. To date, six CERKL mutations have
been  reported  [5–9].  Although  the  CERKL-associated
phenotype was originally characterized as RP [4,5], it is now
clear that mutations in CERKL are responsible for a distinct
form of HRD, characterized by early macular involvement
with roughly parallel cone and rod loss, resulting in a deficit
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in  both  peripheral  and  central  vision.  This  phenotype  is
diagnosed in some patients as CRD [6–10].
The peptidic sequence of the main human CERKL variant
encodes  for  a  protein  of  532  amino  acids  (AA),  with  a
molecular  weight  of  approximately  58  kDa.  CERKL  is  a
homolog of the ceramide kinase (CERK) protein, and both
proteins harbor a kinase domain related to the diacylglycerol
kinases (DAGK) and a pleckstrin homology (PH) domain. In
addition, a CERK-specific region that is downstream from the
catalytic core and bears a putative Ca2+/calmodulin binding
motif is also present in CERKL [11,12]. Several studies have
been  conducted  to  prove  biochemical  similarity  between
CERK and CERKL enzymatic activities. However, so far
there  has  been  no  evidence  that  CERKL  phosphorylates
ceramide or any other lipid substrate in vitro [11,13] or in vivo
[14].
CERKL transcripts are alternatively spliced in the human
retina.  Reverse  Transcription-Polymerase  Chain  Reaction
(RT–PCR)  analysis  of  human  retina  mRNA  led  to  the
identification of six spliced transcripts that resulted in several
protein isoforms [13]. Due to the lack of a specific antibody,
the expression pattern of Cerkl in the mouse retina was studied
using in situ hybridization. Cerkl was shown to be expressed
in the ganglion cell layer (GCL), and to a lesser extent in the
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2539inner nuclear layer (INL) and the photoreceptor cell layer
(PRL) [5]. The subcellular localization of CERKL was studied
using transfection of the full-length cDNA fused to either
green fluorescent protein (GFP) [11,12,15] or haemagglutinin
(HA)-tag [13] into COS-1 [11,12] or COS-7 [13,15] cells. The
tagged  CERKL  protein  was  found  in  many  cellular
compartments, including the cytoplasm, perinuclear region,
and  nucleus;  within  the  nucleus  CERKL  was  abundantly
found  in  nucleoli.  Interestingly,  there  was  intercellular
variability in the expression pattern: CERKL was present in
the nucleus of some, but not all cells within the same culture
[11–13,15]. Two putative nuclear localization signals (NLS)
and two putative nuclear export signals (NES) were identified
in the CERKL protein. Mutagenesis and deletion experiments
indicated that these sequences are involved in CERKL nuclear
import and export in cultured cells [12,15].
In  summary,  CERKL  is  a  novel  gene  of  unknown
function. The severe retinal phenotype associated with human
CERKL mutations indicates that CERKL plays a crucial role
in retinal activity. To further study the role of CERKL in the
normal retina and in pathologic conditions, we developed a
specific  anti-CERKL  antibody  and  used  it  to  study  the
localization  of  the  endogenous  CERKL  protein  in  retina-
derived cell lines and in the mouse retina.
METHODS
Animal  use:  C57BL/6  mice  were  obtained  from  Harlan
Laboratories Inc. (Jerusalem, Israel). Animal care guidelines
comparable to those published by the Institute for Laboratory
Animal Research (Guide for the Care and Use of Laboratory
Animals) were followed and the research was approved by the
Committee  for  the  Supervision  of  Animal  Experiments,
Technion - Israel Institute of Technology.
RNA analysis: Total RNA was isolated from mouse tissues
using  Tri  reagent  (Sigma-Aldrich,  St.  Louis,  MO).  For
expression analysis, reverse transcription (RT) was performed
with 1 µg of total RNA in a 20 µl reaction volume using
Superscript  II  reverse  transcriptase  (Invitrogen,  Carlsbad,
CA) with random primers. PCR was performed with 1 µl of
cDNA  in  a  25  µl  reaction  volume  in  the  presence  of  5×
Readymix (LAROVA GmbH, Teltow, Germany) and 10 pmol
of each forward and reverse primer. Primer sequences were
as follows: mouse Cerk, 5′-GTT CAG CGA GGT GCT GCA
TG-3′ and 5′-CTG CCT GCA CAC GAA GCA CC-3′; mouse
Cerkl,  5′-ATG  TTC  CGG  GGG  AGA  CGC  AGG  AG-3′
(located in exon 1) and 5′-CGT GGA GTC CTT TAG TTT
GTT CCG-3′ (located in exon 2); and β-actin, 5′-GTC CAC
ACC CGC CAC CAG TTC-3′ and 5′-CCA GAG GCA TAC
AGG GAC AGC-3′.
For the identification of Cerkl splice-variants, RT–PCR
was performed with the AccuScript High Fidelity RT–PCR
system (Stratagene, La Jolla, CA). RT priming was performed
with oligo dT (Stratagene). PCR was performed with primers
derived from Cerkl exons 1 and 14 (5′-ATG TTC CGG GGG
AGA CGC AGG AG-3′ and 5′-CAC AAC CAC TCA CAG
GAG AAC-3′). PCR products were gel-purified and cloned
into the pGEM-Teasy plasmid vector (Promega, Madison,
WI).  Plasmids  derived  from  21  independent  clones  were
digested separately by DdeI and HphI endonucleases (New
England  Biolabs,  Beverly,  MA)  and  then  underwent
electrophoresis on a 2% agarose gel. Clones demonstrating
unique digestion patterns were sequenced and analyzed.
Cell  culture:  Cells  were  grown  at  37  °C  and  5%  CO2.
ARPE-19 cells (American Type Culture Collection (ATCC),
Manassas, VA) were grown in DMEM:F12 (1:1) medium
(Biologic Industries, Beit Ha’emek, Israel) containing 10%
fetal bovine serum (FBS), 1% penicillin/streptomycin, and
2.5  mM  L-glutamine;  661W  cells  (obtained  from  Dr.
Muayyad  Al-Ubaidi,  The  University  of  Oklahoma)  were
grown in high-glucose (4.5 g/l) DMEM medium containing
2.5 mM L-glutamine, 110 mg/l sodium pyruvate, 20% FBS,
1%  penicillin/streptomycin  (Biologic  Industries),  40  µg/l
hydrocortisone  21-hemisuccinate,  40  µg/l  progesterone,
32 mg/l putrescine, and 0.004% β-mercaptoethanol (Sigma-
Aldrich).
Generation of an antibody against CERKL: For the generation
of the anti-CERKL antibody (named RA), we synthesized two
short peptides (15 AA each) located in specific mouse CERKL
regions (peptide 1: AA 109–123; peptide 2: AA 485–499).
Each peptide was linked to KLH and a mixture of the two
peptides was injected together with CFA or IFA adjuvants into
rabbits (Sigma-Aldrich, Rehovot, Israel). Rabbits were bled
following 5 injections over a period of 3 months. The antibody
was affinity-purified for a better specificity in western blot
and immunofluorescence analyses.
Expression  of  recombinant  CERKL  isoforms  in  bacteria:
cDNA fragments encoding for CERKL isoforms a’, b’, and
d’ were cloned into the pQE-80L vector (Qiagen, Valencia,
CA), and transformed into the DH5α bacterial strain. The
protein products fused to a 6X-His tag were expressed under
IPTG induction and purified using Ni-NTA resin (Qiagen).
Commercial antibodies: Primary antibodies used were rabbit
polyclonal  antibody  against  GAPDH;  goat  polyclonal
antibody  against  blue  opsin  (OPN1SW;  Santa  Cruz
Biotechnology,  Santa  Cruz,  CA);  and  mouse  monoclonal
antibodies against PAX6 (A. Kawakami, obtained by means
of the Developmental Studies Hybridoma Bank, Department
of  Biology,  The  University  of  Iowa,  IA),  Fibrillarin,  and
Rhodopsin (Abcam, Cambridge, MA). Secondary antibodies
used  were  Cy3-conjugated  donkey  antirabbit  IgG,  Cy2-
conjugated donkey antimouse IgG, Cy2-conjugated donkey
antirabbit IgG, Cy3-conjugated donkey antimouse IgG, Cy3-
conjugated  donkey  antigoat  IgG,  peroxidase-conjugated
AffiniPure goat-antimouse, and goat-antirabbit IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA).
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2540Immunocytochemistry: Cells were seeded on coverslips in 6-
well plates for 24 h, rinsed with phosphate buffered saline
(PBS; 140 mM NaCl, 10 mM Na2HPO4, 2 mM KH2PO4,
2.7 mM KCl, pH 7.4), and fixed with 4% paraformaldehyde
for 20 min at room temperature. After three rinses in 1× PBS,
membrane permeabilization in 0.5% Triton X-100 in 1× PBS
was performed for 10 min, followed by three rinses in 1× PBS,
and 1 h blocking in 5% FBS at room temperature. Cells were
then incubated overnight at 4 °C with primary antibodies in
the detection solution (3% FBS and 0.1% Triton X-100 in 1×
PBS). After rinsing in 1× PBS, cells were incubated with
secondary  antibodies  and  TO-PRO-3  (Invitrogen)  in  the
detection solution for 1 h at room temperature. Coverslips
were  rinsed  with  1×  PBS  and  mounted  onto  slides  using
Vectashield with or without 4',6-Diamidino-2-phenylindole
(DAPI; Vector Laboratories, Burlingame, CA). Images were
Figure 1. Expression analysis of Cerkl in the mouse eye. A: Reverse
Transcription-Polymerase  Chain  Reaction  (RT–PCR)  analysis  of
Cerk (412 bp) and Cerkl expression in mouse brain (Br) and retina
(Ret). Cerkl expression was tested using primers located in exons 1
and 2 (see Figure 2B). The two PCR products obtained for Cerkl (503
and 363 bp) represent different splice-isoforms. B: RT–PCR analysis
of Cerkl in the mouse eye at different developmental time points:
embryonic day 14 (E14),  newborn  (P0),  and  5  months  (5 mo).
The analysis indicates Cerkl expression at all time points tested. β-
actin (Actb; 437 bp product) served as an internal control for RNA
quality and quantity. M: size marker.
taken with a Zeiss Axioscop 2 fluorescent upright microscope
and with a Bio-Rad Radiance 2000 confocal microscope.
Immunohistochemistry:  Whole  eyeballs  were  fixed  in  4%
paraformaldehyde at 4 °C, dehydrated in a graded ethanol
series, and embedded in paraffin. Dewaxed paraffin sections
(8 µm) were examined immunohistochemically as previously
described  [16].  Nuclear  staining  was  obtained  using  TO-
PRO-3  (Invitrogen).  Slides  were  viewed  with  a  Bio-Rad
Radiance 2000 confocal microscope. As a negative control,
the RA antibody was pre-absorbed with fivefold gram-mass
of the recombinant CERKL protein (isoform a’) or with a non-
specific protein (BSA) for 1 h at room temperature.
Western blot analysis: For total protein extraction, retinas
were subjected to 0.5 M HEPES buffer (pH 7.3), followed by
sonication and centrifugation, after which the supernatant was
collected  and  stored  at  −80  °C.  For  the  separation  of
cytoplasmic and nuclear extracts, retinas were homogenized
in lysis buffer (20 mM HEPES, 1 mM MgCl2, 10.8% sucrose,
50 mM β-mercaptoethanol, 1% protease inhibitor cocktail
[Sigma-Aldrich], and 0.5% Nonidet P40 [NP-40]). The lysate
was centrifuged for 5 min at 1500× g, and the supernatant was
separated and used as the cytosolic fraction. The pellet was
washed once with lysis buffer (without NP-40) and proteins
were extracted by adding 2 volumes of low-salt buffer and one
volume of high-salt buffer (20 mM HEPES buffer pH 7.9,
1.5 mM MgCl2, 0.2 mM EDTA, 1% β-mercaptoethanol, 0.5%
protease inhibitor cocktail, 25% glycerol, and 20 mM or 0.8
M  KCl,  respectively).  For  western  blot  analysis,  protein
samples (10 μg each) were boiled  for  10  min  and subjected
to    SDS–PAGE.     They    were     then     transferred      to      a
nitrocellulose membrane (GE Healthcare, Buckinghamshire,
UK), which was incubated with primary antibodies, followed
by peroxidase-conjugated goat-antimouse or goat-antirabbit
secondary  antibodies.  Signals  were  visualized  by
chemiluminescence  using  the  Amersham  ECL  Western
Blotting Analysis System (GE Healthcare).
RESULTS
Cerkl expression and splice-variants in the mouse retina: RT–
PCR analysis revealed that in the mouse retina, Cerkl is highly
expressed, while expression of its homolog, Cerk, is relatively
low (Figure 1A). To examine the ocular expression of Cerkl
at different developmental time points, we performed RT–
PCR analysis of total RNA from the mouse eye. Cerkl was
found to be expressed in the developing mouse eye as early
as embryonic day 14 (E14), although its expression rate in the
embryonic and newborn (P0) eye was lower compared to that
in the adult eye (Figure 1B).
Comparison  of  the  mouse  Cerkl  full-length  cDNA
sequence (GenBank NM_001048176) to the mouse genome
sequence at the UCSC Genome Browser initially revealed that
the mouse gene comprises 13 exons. The exon structure of
human and mouse CERKL genes is highly conserved (Figure
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25412).  Tuson  et  al.  [13]  identified  four  main  CERKL  splice-
variants in the human retina (isoforms a-d), and two additional
non  in-frame  variants  that  would  generate  prematurely
truncated proteins (AY690333 and AY690332; Figure 2A,
isoforms e and f, respectively). To identify the splice-variants
of  Cerkl  in  the  mouse  retina,  we  performed  RT–PCR
amplification of RNA from adult and embryonic (E14) retina.
Four different Cerkl splice-isoforms were identified in the
adult  retina  (variants  a’-d’).  In  the  embryo,  five  different
isoforms  were  detected  (isoforms  a’,  d’-g’).  One  of  the
embryonic isoforms (isoform g’) included a novel exon of 156
bp (exon 12). Therefore, the total number of exons in the
mouse Cerkl gene is 14, as in the human ortholog (Figure 2B).
Three of the identified mouse retinal isoforms (isoforms
a’-c’) encode for relatively long protein products including
the  PH  domain,  and  the  DAGK  and  CERK  homology
domains. The other isoforms encode for very short protein
products, which include only a full or a partial PH domain
(Figure 2B). Two of the isoforms (isoforms d’ and g’) differ
by the absence or presence of exon 12. However, they both
Figure  2.  CERKL  gene  and  splice-
variants in human and mouse retina. A
schematic  representation  of  CERKL
genes (drawn to scale), splice-variants
(left  panels),  and  expected  protein
products (right panels) is shown. In the
splice-variants illustrations, filled boxes
represent coding exons, and open boxes
represent  non-coding  exons.
Alternatively spliced exons are marked
in  red.  In  the  protein  products
illustrations, the PH, DAGK, and CERK
homology domains are indicated. The
borders of each domain are marked by
their  amino  acid  positions,  indicated
above each protein. The breaks between
exons are indicated below each protein.
Protein  molecular  weight  in  kDa  is
shown on the right. A: Human CERKL
gene  and  splice-variants  previously
identified in the human retina. Variants
e and f correspond to AY690333 and
AY690332 [13]. B: Mouse Cerkl gene
and splice-variants found in the mature
and embryonic (E14) mouse retina. Two
of  the   mouse  isoforms  (isoforms  d’
and  g’)  encode  for  the  same short
protein   product.   Mouse  isoform   a’,
which   is   present   in  both  adult  and
embryonic   samples,   is   equivalent   to
human isoform a, and mouse isoform f’
is  equivalent  to  human  isoform  f.
Locations  of  PCR  primers  used  for
RT–PCR analysis and for splice-variant
identification  (forward  primer located
in exon 1 and  reverse  primers located
in  exons  2  and  14) are indicated by
arrows  above the schematic represent-
ation of the murine gene.
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2542harbor  exon  2a,  which  creates  a  frameshift  and  early
termination of translation; therefore, both encode for the same
short  protein  product  of  109  AA  (Figure  2B).  Only  two
isoforms (isoforms a’ and d’) were present in both adult and
embryonic samples. Comparison of human CERKL retinal
splice-isoforms reported by Tuson et al. [13] to mouse Cerkl
retinal splice-isoforms identified in this study indicated that
only two are equivalent. Mouse isoform a’ is equivalent to
human isoform a, and mouse isoform f’ is equivalent to human
isoform f (AY690332; Figure 2).
Generation and evaluation of an anti-CERKL antibody: To
study the expression pattern and function of CERKL, we
Figure 3. Verification of the specificity of the anti-CERKL antibody RA. A: Western blot analysis of mouse retinal extract with the affinity-
purified RA antibody. The antibody detects a main specific band, which corresponds to the expected size of the primary and most abundant
CERKL isoform in the adult mouse retina (isoform a’, 58 kDa). Two additional fainter bands slightly higher than 51 kDa, corresponding to
isoforms b’ and c’ (55 and 53 kDa, respectively), can also be observed. All three bands are completely absent following pre-absorption of the
RA antibody with the recombinant CERKL protein (right panel), but not with a non-specific protein (BSA; left panel). B: Western blot analysis
of extracts from bacteria transformed with mouse Cerkl retinal isoforms a’ (58 kDa), b’ (55 kDa), and d’ (12 kDa). The RA antibody detects
proteins of the expected sizes in IPTG-induced, but not in un-induced bacterial extracts. C: Western blot analysis of protein extracts from the
ARPE-19 and 661W cell lines. In the mouse-derived cell line, 661W, a major band of approximately 58 kDa, which corresponds to mouse
CERKL isoform a’ is detected. In the human-derived cell line, ARPE-19, two bands corresponding to human CERKL isoforms c and d (46
and 51 kDa, respectively) are detected. D: Immunostaining of ARPE-19 cells is omitted following pre-absorption of the RA antibody (green)
with the recombinant CERKL protein (right panel), but not with a non-specific protein (BSA; left panel). Nuclei are stained with TO-PRO-3
(blue). Scale bar, 20 µm. E: Immunostaining of a mouse retina section is omitted following pre-absorption of the RA antibody (green) with
the recombinant CERKL protein (right panel), but not with a non-specific protein (BSA; left panel). Nuclei are stained with TO-PRO-3 (blue).
Scale bar, 20 µm.
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2543Figure 4. CERKL subcellular localization in ARPE-19 cells. Cells were stained with the RA anti-CERKL antibody (red) and with DAPI for
nuclear staining (blue). A-C: The subcellular localization of CERKL is variable. It can be located in both the nucleus and the cytoplasm
(arrowhead), or only in the cytoplasm (arrows). In many cells, CERKL is concentrated in the perinuclear region (asterisks). Scale bar, 50 µm.
D-F: A cell in which CERKL is absent from the nucleus. Scale bar, 10 µm. G-I: A cell in which CERKL is concentrated in the nucleus. Scale
bar, 10 µm. J-L: CERKL is absent from nucleoli (arrows), which are stained by the nucleolar marker Fibrillarin (green). Scale bar, 10 µm.
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2544developed  a  specific  anti-CERKL  antibody  (RA).  The
antibody was raised in rabbit against a mixture of two short
peptides (15 AA each). The specificity of the RA antibody
was initially tested using western blot analysis. The antibody
detected a main specific band that corresponds to the expected
size of the primary and most abundant CERKL isoform in the
adult  mouse  retina  (isoform  a’,  58  kDa).  Two  additional
fainter  bands  slightly  higher  than  51  kDa  could  also  be
observed, which may correspond to isoforms b’ and c’ (55 and
53  kDa,  respectively).  All  three  bands  were  completely
omitted following pre-absorption of the RA antibody with the
recombinant  CERKL  protein,  but  not  with  a  non-specific
protein (BSA; Figure 3A).
To further verify the specificity of the RA antibody, we
expressed three CERKL mouse retinal isoforms (isoforms a’,
b’, and d’) as recombinant proteins in bacteria under an IPTG-
inducible  promoter.  Western  blot  analysis  with  the  RA
antibody detected proteins of the expected sizes in induced,
but not in un-induced bacterial extracts (Figure 3B).
Subcellular localization of CERKL in cultured cells: To date,
the  subcellular  localization  of  CERKL  was  tested  by
overexpression of the tagged protein in various cell lines that
were not of retinal origin [11,13]. Therefore, we used the anti-
CERKL antibody generated in this study by our group (RA)
to test the subcellular localization of the endogenous CERKL
in  two  cell  lines:  ARPE-19  (derived  from  human  retinal
pigmented epithelium [RPE]) [17] and 661W (derived from
mouse  photoreceptor  cells)  [18].  We  initially  performed
western blot analysis of protein extracts from these two cell
lines with the RA antibody (Figure 3C). In the mouse-derived
cell  line,  661W,  a  major  band  of  approximately  58  kDa
corresponding to mouse CERKL isoform a’ (Figure 2B) was
detected; whereas, in the human-derived cell line, ARPE-19,
two bands corresponding to human CERKL isoforms c and d
(46 and 51 kDa, respectively) (Figure 2A) were detected.
Immunostaining  of  ARPE-19  cells  with  the  anti-CERKL
antibody revealed that the subcellular localization of CERKL
is variable (Figure 4). CERKL is diffusely distributed in the
cytoplasm, and in many cells, it is highly concentrated in the
perinuclear region (Figure 4A-C). In most cells, CERKL is
also present in the nucleus (Figure 4A-C,G-L); however, in a
few cells in each field, CERKL was completely absent from
Figure 5. CERKL subcellular localization in 661W cells. Cells were stained with the RA anti-CERKL antibody (red) and with TO-PRO-3 for
nuclear staining (blue). A-C: CERKL can be located in both the nucleus and the cytoplasm, where it is concentrated in the perinuclear region.
Scale bar, 20 µm. D-F: CERKL is absent from nucleoli (arrows), which are stained by the nucleolar marker Fibrillarin (green). Scale bar, 20
µm.
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2545Figure 6. CERKL expression pattern in the mouse retina. Serial sagittal sections of adult mouse retina were immunostained with the RA anti-
CERKL antibody. A-C: CERKL staining (green) shows expression in the photoreceptor cell layer (PRL), the inner nuclear layer (INL), and
the ganglion cell layer (GCL). D-F: Double staining for CERKL (green) and PAX6 (red), a marker for amacrine cells, in the INL and GCL.
G-I: Double staining for CERKL (green) and OPN1 (red), a marker for cone photoreceptor cells. The insert in panel I shows a higher
magnification of a double-stained cone photoreceptor. J-L: Double staining for CERKL (green) and RHO (rhodopsin; red), a marker for rod
photoreceptor cells. Nuclei are stained with TO-PRO-3 (blue). Note that CERKL is highly expressed in cone photoreceptors, while its
expression level in rod photoreceptors is very low. No staining was observed when sections were stained with serum from pre-immune rabbits
or with secondary antibody only (data not shown). PRL, photoreceptor layer; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion
cell layer. Scale bars, 20 µm.
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2546the  nucleus  (Figure  4A-F).  We  hypothesized  that  the
localization of CERKL to the nucleus may be correlated to the
cell cycle state, but no such correlation was found (data not
shown). Staining of ARPE-19 cells was eliminated following
pre-absorption  of  the  RA  antibody  with  the  recombinant
CERKL  protein,  further  indicating  the  specificity  of  this
antibody (Figure 3D).
The subcellular localization of CERKL in 661W cells
was more uniform. In most cells, CERKL was distributed in
both the cytoplasm and the nucleus, and highly concentrated
in the perinuclear region (Figure 5A-C). Interestingly, while
in previous studies the exogenously expressed CERKL was
found to be concentrated in nucleoli [11], in both ARPE-19
and 661W cells, endogenous CERKL was consistently absent
from nucleoli (Figure 4J-L and Figure 5D-F). This finding
could be explained by cell type differences. Alternatively, it
is possible that the previously observed nucleolar localization
was an artifact of overexpression, which does not reflect the
localization of CERKL at physiologic levels.
Localization of CERKL in the mouse retina: Immunostaining
of adult mouse retinas with the RA anti-CERKL antibody
indicated that CERKL was located in the GCL, INL, and PRL
(Figure 6A-C). No staining was observed in the RPE (data not
shown).  These  results  are  in  agreement  with  previously
published  data  based  on  in  situ  hybridization [5]. However,
the use of a specific antibody enabled a  more detailed analy-
sis in the present investigation. Within the INL, CERKL was
located in amacrine cells, as confirmed by its co-localization
with  the  amacrine  cell  marker  PAX6  (Figure  6D-F).
Interestingly, in the PRL, CERKL was highly expressed in the
outer segments of cone photoreceptors, as indicated by its co-
localization with OPN1, a cone-specific marker [19] (Figure
6G-I). In contrast, the expression level of CERKL in rod
photoreceptors  was  very  low  (Figure  6J-L).  Staining  was
completely  absent  following  pre-absorption  of  the  RA
antibody with the recombinant CERKL protein (Figure 3E).
In  CERKL-positive  mouse  retinal  cell  types  in  situ,
CERKL  was  mostly  located  in  the  cytoplasm.  In
photoreceptors and amacrine cells, CERKL was exclusively
located  in  the  cytoplasm  and  nuclear  staining  was  not
observed in these cell types (Figure 6D-L). In ganglion cells,
CERKL  was  mostly  located  in  the  cytoplasm;  however,
nuclear staining was observed in a few ganglion cells (Figure
6D-F). These results were obtained in both light- and dark-
adapted retinas. To further verify this finding, we performed
western blot analysis of cytoplasmic versus nuclear fractions
derived from mouse retinas. CERKL was exclusively detected
in the cytoplasmic fraction (Figure 7).
DISCUSSION
CERKL is a novel gene of unknown function. It was named
CERKL due to its homology to CERK [11]. Our analysis
revealed that in the mouse retina, Cerkl is highly expressed,
but Cerk expression is very low (Figure 1A). Based on this
finding, it may be hypothesized that in the retina, CERKL
replaces CERK. However, to date, there is no evidence that
these two proteins actually share a similar function. Unlike
CERK, CERKL does not phosphorylate ceramide or any other
lipid substrate in vitro [11,13]. Moreover, in the retinas of
Cerk-deficient  mice,  ceramide  levels  were  increased  and
ceramide-1-phosphate  (C1P)  levels  were  decreased.  In
contrast,  wildtype  levels  of  both  ceramide  and  C1P  were
found in the retina of Cerkl null mice [14]. These findings
indicate that despite its relatively low expression level in the
retina, CERK, and not CERKL, is responsible for ceramide
phosphorylation in this tissue [14].
The  high  expression  level  of  Cerkl  in  the  retina,  in
addition  to  the  severe  retinal  phenotype  associated  with
human  CERKL  mutations,  indicate  that  this  gene  plays  a
crucial  role  in  retinal  activity.  Moreover,  we  found  that
Cerkl is expressed in the mouse eye as early as E14 (Figure
1B), which suggests that Cerkl may be important for retinal
development, in addition to its role in the mature retina. Tuson
et  al.  [13]  reported  that  the  overexpression  of  CERKL
prevented cells from entering apoptosis induced by oxidative
stress conditions, which implies a protective role for CERKL
in  photoreceptors.  This  possibility  requires  further
investigation.
CERKL  transcripts  are  alternatively  spliced  in  both
human and mouse retinas. Tuson et al. [13] identified four
main CERKL splice-variants in the human retina (isoforms a-
d),  and  two  additional  non  in-frame  variants  that  would
generate prematurely truncated proteins (isoforms e and f).
They considered these two variants to be aberrant transcripts.
Since the human exon 4b, which is included only in isoform
b,  has  no  equivalent  in  the  mouse  gene  (Figure  2),  they
speculated  that  in  the  mouse  retina,  there  are  only  three
Cerkl splice-isoforms [13]. However, we identified a total of
seven  distinct  Cerkl  splice-variants  in  the  mouse  retina.
Figure 7. CERKL expression in the cytoplasm and nuclei of adult
mouse retina. Western blot analysis was conducted on nuclear and
cytoplasmic fractions of adult mouse retinas with an anti-CERKL
antibody. PAX6 served as a positive control for the nuclear fraction.
GAPDH served as a positive control for the cytoplasmic fraction.
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product of 525 AA, was present in the human retina as well
(variant a). Interestingly, the only other variant common to
both  human  and  mouse  was  mouse  isoform  f’,  which  is
equivalent to human isoform f (AY690332; Figure 2). The
presence  of  this  short  isoform  in  both  human  and  mouse
retinas indicates that it is probably not an aberrant product,
and may have biologic significance. For example, it may have
a regulatory role at the RNA or protein level.
Our findings regarding the expression pattern of CERKL
within the mouse retina are noteworthy. Previously, based on
in situ hybridization, Cerkl was reported to be expressed in
photoreceptors in general [5], but our analysis indicates that
in the murine retina, CERKL is highly expressed in cone
photoreceptors,  with  a  very  low  expression  level  in  rods
(Figure  6).  This  finding  correlates  with  the  CERKL-
associated phenotype in humans, which is characterized by a
significant involvement of cones, and is often diagnosed as
CRD [6,8]. Nevertheless, based on this expression pattern, it
is  difficult  to  explain  rod  degeneration  in  humans  with
CERKL mutations. It is possible that in the human retina, the
expression level of CERKL in rods is higher than in the murine
retina. Alternatively, despite its low expression level, CERKL
may still be crucial for rod survival. A third option is that rod
degeneration may be secondary to cone degeneration. This
option is less likely, as at least in some patients with CERKL
mutations, a similar degree of rod and cone dysfunction is
observed [8].
Within cone photoreceptors, CERKL was found in the
outer  segments,  which  are  highly  specialized  organelles
consisting of a series of discrete membranous discs that are
densely packed with rhodopsin and other proteins involved in
the phototransduction cascade. Moreover, they lack most of
the proteins involved in other cellular functions [20]. It may
be hypothesized that CERKL’s function is directly linked to
the phototransduction mechanism; however, this possibility
requires further investigation.
Another important finding from our analysis is related to
the intracellular localization of CERKL, and specifically to its
presence in the nucleus. Two putative NLS and NES were
identified  in  the  CERKL  protein,  and  these  appear  to  be
responsible  for  the  trafficking  of  CERKL  between  the
cytoplasm and the nucleus in cultured cells [12,15]. CERKL
was detected in the nucleus in several cell lines, including
retina-derived cell lines of both human and mouse origin
(Figure 4 and Figure 5). Moreover, a missense mutation that
alters NLS2 was identified in members of a Pakistani family
affected with retinal degeneration [7], and it was suggested
that  a  defective  nucleocytoplasmic  shuttling  mechanism
might  be  responsible  for  retinal  degeneration  in  CERKL
mutants [12]. Our analysis indicated that in cultured cells,
there is intercellular variability regarding the localization of
CERKL.  In  ARPE-19  cells,  CERKL  was  located  in  the
nucleus in some, but not all cells within the same culture
(Figure 4), a finding made previously [11–13,15]. The reason
for this intercellular variability and the signals that affect the
nuclear  localization  of  CERKL  are  currently  unknown.
Furthermore, we found that CERKL is almost exclusively
localized  to  the  cytoplasm  in  the  murine  retina  in  situ,
following  both  dark-  and  light-  adaptation  (Figure  6  and
Figure 7). Whether CERKL is actually transported to the
nucleus of retinal cells in vivo under certain conditions (e.g.,
following ultraviolet (UV) radiation or oxidative stress) and
the  functional  significance  of  the  NLS  remain  to  be
discovered.
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